Abstract-The evolutionary conserved Wnt signaling pathway regulates cardiogenesis. However, members of the Wnt pathway are also expressed in the adult heart. Although Wnt-signaling is quiescent under normal conditions, we noticed activation on pathological stress of the heart, such as chronic afterload increase. To examine the role of Wnt signaling on the postnatal heart, we modified the expression and function of the Wnt regulator dishevelled 1 (Dvl-1) both in transgenic mice with cardiac-specific overexpression of Dvl-1 (Dvl-1-Tg) and in cultured cardiac myocytes. Dvl-1-Tg mice (3 months) had severe cardiac hypertrophy (heart weight:body weight ratio: 5.2Ϯ0.3 mg/g wild-type [WT] versus 6.4Ϯ0.7 mg/g Dvl-1-Tg; PϽ0.01), an increase in cardiomyocyte size (86% increase in Dvl-1-Tg compared with WT; PϽ0.01) and marked raise of atrial natriuretic factor expression (12-fold increase versus WT; PϽ0.01). Hypertrophy was associated with left ventricular dilatation in Dvl-1-Tg and a reduction of ejection fraction (4.4Ϯ0.1 mm versus 5.5Ϯ0.2 mm, 80Ϯ2% and 43Ϯ4% in WT versus Dvl-1-Tg, respectively; PϽ0.01). Transgenic animals died prematurely before 6 months of age. Both canonical as well as noncanonical Wnt signaling branches were activated in the Dvl-1-Tg animals. Small interfering RNA-mediated depletion of Dvl-1 was used to further characterize the role of Dvl-1 in cardiac myocytes. Whereas baseline parameters were unaltered, ␤-adrenergic hypertrophic response was abrogated in Dvl-1 knockdown cardiac myocytes, indicating a mandatory role in ␤-adrenergic stimulation. Therefore, activation of Wnt signaling is sufficient and critical for the induction of myocardial hypertrophy and cardiomyopathy. Key Words: Wnt signaling Ⅲ cardiac hypertrophy Ⅲ experimental heart failure A fter conditions of increased wall stress, the myocardium may adopt by a process called remodeling. Left ventricular remodeling is considered to be a maladaptive process characterized by myocyte hypertrophy, an increase in myocardial fibrosis, and left ventricular dilatation. Remodeling may induce clinically overt heart failure and contributes to increased mortality after myocardial infarction. Other than standard heart failure medications, there are no treatment options available targeted to maladaptive remodeling. On pathological stress, the heart reactivates a number of signaling pathways, which traditionally were thought to be operational primarily in the developing organism. The Wnt pathway is an evolutionary conserved signaling mechanism with a critical function in tumor growth 1 and cardiogenesis. 2, 3 However, members of the Wnt pathway are also expressed in the normal adult heart. 4 -7 Thus, for example, the Frizzled (Fz) class of cell surface receptors of Wnt proteins, including Fz1 and Fz2, is expressed in human myocardium. 7 In infarcted hearts, Fz2 expression is considerably enhanced, 8 and in failing ventricles of humans, mRNA levels of secreted Fz-related proteins 3 and 4, which are endogenous Wnt antagonists, are elevated, leading to attenuation of the Wnt/ ␤-catenin pathway. 9,10 Furthermore, Wnt3a is upregulated in ischemic cardiomyocytes. 11 Wnt proteins initiate their signaling pathways by binding to their receptors, either Fz or a complex of Fz and low-density lipoprotein receptor-related protein 5/6. Dishevelled (Dvl) is one of the multimodule proteins of the Wnt pathway and acts as a positive regulator of the Wnt pathway. 12 Although the DIX and PDZ domains of Dvl-1 mainly mediate ␤-catenin-dependent (canonical) Wnt signaling, the DEP domain is important for its ␤-catenin-independent (noncanonical) activity. 13, 14 In this study, we demonstrate that Dvl-1 protein expression is increased in the stable phase of cardiac hypertrophy after aortic banding and in heart failure. Furthermore, we demonstrate that activation of Wnt signaling through cardiacspecific overexpression of Dvl-1 leads to severe cardiomyopathy and provide the first evidence that both canonical and noncanonical Wnt signaling pathways are involved in cardiac hypertrophy. 
A fter conditions of increased wall stress, the myocardium may adopt by a process called remodeling. Left ventricular remodeling is considered to be a maladaptive process characterized by myocyte hypertrophy, an increase in myocardial fibrosis, and left ventricular dilatation. Remodeling may induce clinically overt heart failure and contributes to increased mortality after myocardial infarction. Other than standard heart failure medications, there are no treatment options available targeted to maladaptive remodeling. On pathological stress, the heart reactivates a number of signaling pathways, which traditionally were thought to be operational primarily in the developing organism. The Wnt pathway is an evolutionary conserved signaling mechanism with a critical function in tumor growth 1 and cardiogenesis. 2, 3 However, members of the Wnt pathway are also expressed in the normal adult heart. 4 -7 Thus, for example, the Frizzled (Fz) class of cell surface receptors of Wnt proteins, including Fz1 and Fz2, is expressed in human myocardium. 7 In infarcted hearts, Fz2 expression is considerably enhanced, 8 and in failing ventricles of humans, mRNA levels of secreted Fz-related proteins 3 and 4, which are endogenous Wnt antagonists, are elevated, leading to attenuation of the Wnt/ ␤-catenin pathway. 9, 10 Furthermore, Wnt3a is upregulated in ischemic cardiomyocytes. 11 Wnt proteins initiate their signaling pathways by binding to their receptors, either Fz or a complex of Fz and low-density lipoprotein receptor-related protein 5/6. Dishevelled (Dvl) is one of the multimodule proteins of the Wnt pathway and acts as a positive regulator of the Wnt pathway. 12 Although the DIX and PDZ domains of Dvl-1 mainly mediate ␤-catenin-dependent (canonical) Wnt signaling, the DEP domain is important for its ␤-catenin-independent (noncanonical) activity. 13, 14 In this study, we demonstrate that Dvl-1 protein expression is increased in the stable phase of cardiac hypertrophy after aortic banding and in heart failure. Furthermore, we demonstrate that activation of Wnt signaling through cardiacspecific overexpression of Dvl-1 leads to severe cardiomyopathy and provide the first evidence that both canonical and noncanonical Wnt signaling pathways are involved in cardiac hypertrophy.
Materials and Methods
The investigation conforms with the Guide for the Care and Use of Laboratory Animals published by the National Institutes of Health and was approved by the local animal ethics review board (approval No. 40631), as well as by the Regierungspräsidium Karlsruhe (project No. 35-9185.81/G-131/06 for the rat and 35-9185.81/ G81-08 for the mouse model). Isolation and culture of cardiac myocytes, small interfering RNA (siRNA) transfection, immunoblot analyses, quantitative real-time PCR, and determination of myocyte surface area were performed as described previously. 15 For descriptions about specifics in the methods used in this study and the generation of transgenic mice please refer to the online Data Supplement at http://hyper.ahajournals.org.
Aortic Banding and Heart Failure Model
Aortic banding was induced in rats by clipping the ascending aorta just above the coronary arteries. Banded animals develop compensated cardiac hypertrophy without heart failure after 4 weeks. Heart failure was induced in a swine model of atrial fibrillation (AF) induced by pacemaker stimulation. The model and details about pacemaker implantation and further experimental settings have been described previously. 16 
Histopathology
Hematoxylin and eosin, Masson trichrome, and TUNEL staining were performed according to standard protocols. Please see the online Data Supplement for a complete description of methods related to histopathology used for these studies.
Echocardiography and Pressure-Volume Loop Analysis
Echocardiography and invasive hemodynamics with conductance catheters were done under light anesthesia with isoflurane as outlined in detail in the online Data Supplement.
Statistical Analysis
Data are reported as the meanϮSEM. Difference between the groups was compared by 2-tailed Student t test or by multiple ANOVA, when applicable. A post hoc test was performed by the method of Tukey. Significance was accepted at the PϽ0.05 level.
Results

Pressure Overload and Chronic Heart Failure Reactivate Myocardial Wnt Signaling
In aortic stenosis tissues in the stable phase of cardiac hypertrophy 4 weeks after aortic banding an increased protein expression of Dvl-1 was observed ( Figure 1A) . Furthermore, in a porcine model of persistent AF with chronic heart failure, 16 Western blot analysis of left ventricular tissues revealed an overexpression of Dvl-1 ( Figure 1B ). This prompted us to further study the role of Dvl-1 in the postnatal heart.
Activation of Wnt Signaling Leads to Cardiomyopathy and Premature Death
To study the role of Wnt signaling in the postnatal heart, we generated mice with cardiac-specific overexpression of Dvl-1 under the control of an ␣-myosin heavy chain promoter ( Figures 1C and S1 ). All of the experiments were performed in animals 3 months of age unless stated otherwise.
Severe cardiomyopathy in Dvl-1 transgenic (Tg) mice was evident from gross pathology of transgenic hearts ( Figure 1D ). Premature death occurred in Dvl-1-Tg mice before the age of 6 months ( Figure 1E ). Postmortem analysis of these animals Contractility of the left ventricle was further assessed by pressure-volume loop analysis. The increase in end-diastolic and end-systolic volumes was associated with a decrease in the maximal rise of left ventricular pressure (dp/dt maximum: 8742Ϯ664 versus 5022Ϯ322 mm Hg/s), indicating impairment of contractility in Dvl-1-Tg mice ( Figure 2B and 2C). Reduction in dp/dt minimum levels (Ϫ8511Ϯ402 versus 4785Ϯ311 mm Hg/s) and the increase in the time constant of isovolumic relaxation (Tau-Glantz) levels demonstrate diastolic dysfunction in the Dvl-1-Tg mice (7.3Ϯ0.3 versus 15.08Ϯ2.0 m/s; PϽ0.05; Figure 2C ). Taken together, echocardiography and invasive hemodynamics consistently demonstrated a significant impairment of myocardial function in Dvl-1-Tg mice.
Dvl-1 Is Sufficient and Critical to Induce Cardiac Hypertrophy
Myocardial dysfunction in Dvl-1-Tg mice was associated with myocardial hypertrophy and morphological characteristics of adverse remodeling. Heart weight:body weight ratio (in milligrams per gram) of fresh tissue (6.2Ϯ0.5 versus 4.8Ϯ0.2 mg/g; PϽ0.01) and heart weight:tibia length ratio (in milligrams per milliliter) were significantly higher in Dvl-1-Tg mice (10.36Ϯ0.8 versus 7.1Ϯ0.2 mg/mm; Figure 3A ). Furthermore, increased cardiomyocyte size in Dvl-1-Tg mice shown by hematoxylin and eosin staining ( Figure 3A and 3B) and increased fibrosis with extensive collagen deposition in C, Deterioration in cardiac function was observed in Dvl-1-Tg mice when assessed with pressure-volume conductance system. Increase in end-systolic volume and the Tau-Glantz levels indicate the onset of diastolic dysfunction, and the maximum derivative of change in pressure rise over time (dp/dt max) and the maximum derivative of change in pressure fall over time (dp/dt min) demonstrate a continual decline over time in Dvl-1-Tg mice; nϭ14 Dvl-1-Tg and nϭ9 WT mice. Data are meanϮSEM; *PϽ0.05, **PϽ0.01 vs control.
the left ventricle as observed by Masson trichrome staining were observed ( Figure 3C ). Atrial natriuretic factor, a molecular marker of cardiac hypertrophy, showed a 12-fold increase on mRNA level in Dvl-1-Tg mice when compared with WT mice ( Figure 3D ). Heart failure in Dvl-1-Tg was accompanied by a significant increase in apoptosis in Dvl-1-Tg mice ( Figure S2 ). We further examined the effect of siRNA-mediated depletion of Dvl-1 in cardiac myocytes. Although no baseline alterations in unstimulated cells were observed when Dvl-1 was depleted, isoproterenol challenge failed to induce a hypertrophic response in cardiac myocytes under these conditions, indicating that Dvl-1 is necessary for ␤-adrenergic cardiac hypertrophy (Figure 4) .
Involvement of Canonical and Noncanonical Wnt Signaling Pathways in Cardiac Hypertrophy
Overexpression of Dvl-1 leads to the accumulation of ␤-catenin, the key molecule of canonical Wnt signaling ( Figures 5A and S3 ). ␤-Catenin further translocates into the nucleus and interacts with the lymphoid enhancer factor/T cell factor family of transcription factors. 17 ␤-Catenin thereby induces the transcription of its target genes. In line, the proto-oncogenes cyclin D1 and c-Myc were upregulated in Dvl-1-Tg mice ( Figures 5A, S3, and S4) . Moreover, mRNA expression of axin 2, a prominent indicator of activation of the canonical Wnt signaling pathway, 18 was increased ( Figure  S5 ). In addition, noncanonical pathways were found to be activated after Dvl-1-induced activation of Wnt signaling. Noncanonical Wnt signaling divides into 3 major branches mediated through c-Jun N-terminal kinases (JNKs), protein kinase C (PKC), and Ca 2ϩ /calmodulin-dependent protein kinase II (CAMKII). In Dvl-1-Tg mice, JNK signaling was enhanced. Furthermore, CAMKII and PKC signalings were activated ( Figures 5B and S6) . Phosphorylation of CAMKII was associated with increased phosphorylation of histone deacetylase 4, a class II histone deacetylase that has been associated with cardiac hypertrophy 19 ( Figures 5C and S7) .
Because PKC and CAMKII are known to be activated during the course of cardiac hypertrophy, we further investigated whether activation of these molecules was the cause or consequence of the cardiomyopathic phenotype of Dvl-1-Tg animals. Activation of these pathways could be found in 6-week-old animals in which the cardiac phenotype was still identical to WT animals ( Figure S8 ), indicating a causal link of noncanonical Wnt signaling to cardiomyopathy.
Discussion
Wnt signaling is highly conserved among species and plays a major role in development and tumorigenesis. In this study we identified Wnt signaling to be central to myocardial hypertrophy and function. Our data demonstrated activation of Wnt signaling in the chronic phase of pressure-overload hypertrophy in rats, as well as in a porcine model of AF with chronic heart failure.
Molecules and pathways that are differentially regulated in embryonic and fully developed myocardium may be re- 
Malekar et al Wnt Signaling Induces Maladaptive Hypertrophy
expressed under conditions of inappropriate stress or pathological stimuli. The molecules involved in Wnt signaling share these properties. Wnt signaling is critical for proper myocardial differentiation but silenced in normal fully differentiated myocardium. Our finding that Wnt signaling is activated in the overloaded heart suggests not only a specific role in the disease process but may also provide novel opportunities for treatment of myocardial hypertrophy and heart failure. This notion is further supported by our finding that depletion of Dvl-1 did not lead to alterations of baseline morphology, which indicates that Dvl-1 is not centrally involved in normal cardiac growth but primarily appears to mediate pathological hypertrophy, thus serving as an option to specifically target maladaptive cardiac hypertrophy. The function of Wnt signaling in the postnatal heart has not been systematically examined thus far. Few studies have investigated the role of ␤-catenin-dependent signaling. In this context, Haq et al 20 demonstrated that activation of ␤-catenin is not only sufficient but also necessary to induce cardiomyocyte hypertrophy. Interestingly, the data demonstrate that stabilization of ␤-catenin apparently can occur through stimulation of G protein-coupled receptors, 20 suggesting that ␤-catenin participates here in a Wnt independent manner, 21 which has also been demonstrated by Liu et al. 22 This finding is supported by results from this study demonstrating that ␤-adrenergic stimulation, which activates G sdependent signaling, depends on the presence of Dvl-1 to induce cardiomyocyte hypertrophy.
The importance of ␤-catenin-dependent signaling for the development of cardiac hypertrophy has also been confirmed in vivo using mice with conditional cardiac-specific knockout of ␤-catenin. 23 In line with these previous findings, Qu et al 24 demonstrated that cardiac-specific haploinsufficiency for ␤-catenin attenuates pressure-overload-induced cardiac hypertrophy. In another study by Hahn et al, 25 overexpression of a constitutively active form of ␤-catenin led to spontaneous hypertrophy of cardiomyocytes in culture. van de Schans et al 26 reported that mice lacking the Dvl-1 gene showed attenuated hypertrophic response to pressure overload, which was related to altered activity of glycogen synthase kinase 3␤ and AKT. Of note in this model, where deletion of Dvl-1 was not restricted to the heart, an increase of ␤-catenin was inhibited after aortic banding, whereas downstream targets of ␤-catenin were not regulated. Conflicting with these previous results, Baurand et al 27 reported spontaneous cardiac hypertrophy in ␤-catenin-depleted mice and attenuation of angiotensin II-induced cardiac hypertrophy in mice with stabilized ␤-catenin. These findings, however, were on the basis of analysis of cardiomyocyte size and atrial natriuretic factor expression, whereas total heart weight was not measured. Although cyclin D1 is a known target of ␤-catenin, Haq et al 20 found that this gene is not activated in cardiomyocytes in vitro when ␤-catenin is overexpressed. However, in our mouse model, a significant upregulation of cyclin D1 was observed, which suggests the activation of the lymphoid enhancer factor/T cell factor family of target genes in the heart in vivo.
By contrast to canonical Wnt signaling, the role of noncanonical Wnt signaling in postnatal hearts and specifically its potential significance in the context of myocardial disorders have not been investigated thus far. This is surprising given that molecules such as PKC, CAMKII, and Rho are not only members of noncanonical Wnt signaling 28 but are also involved in myocardial remodeling. In this context, translocation modification has confirmed that PKC␦ is a critical mediator of postischemic cardiomyocyte necrosis and contractile dysfunction in mice, rats, and pigs 29 and that PKC␣ regulates cardiac contractility and mediates the development of heart failure. 30 Recently, Backs et al 31 showed that CaMKII␦-null mice have attenuated response to pressure overload.
In our model we demonstrate for the first time that both canonical and noncanonical Wnt pathways are activated in Dvl-1-Tg mice leading to a severe cardiomyopathy phenotype. Key proteins of the canonical (␤-catenin, cyclin D1, c-Myc, and axin 2), as well of the noncanonical, Wnt pathway (JNK, PKC, and CAMKII) are upregulated, suggesting the involvement of both Wnt branches in cardiac hypertrophy ( Figure 6 ). The absence of activated Wnt signaling prevents hypertrophic cardiomyocyte growth.
Perspectives
Our data provide compelling evidence that all of the branches of Wnt signaling are involved in cardiac hypertrophy and cardiomyopathy. Inhibition of Dvl-1-dependent Wnt signaling could serve as a lead target for the treatment of cardiac hypertrophy.
Online Supplement
Wnt-signaling is critical for maladaptive cardiac hypertrophy and accelerates myocardial remodeling
Pressure-volume loop analysis
Briefly this method is based on measuring the time-varying electrical conductance signal of two segments of blood in the LV from which the total LV volume is calculated. The raw conductance volumes were corrected for parallel conductance by the hypertonic saline dilution method. Data were digitized with a sampling rate of 1000Hz and recorded on a PC using software package (Chart, AD instruments). Subsequent analysis of pressure-volume loops was done by using PVAN software (Millar Instruments Inc). 
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